Sichenzia Ross Ference Carmel LLP Represents A2Z Cust2Mate Solutions Corp. in $30 Million Public Offering and Concurrent Registered Direct Offering By Sichenzia Ross Ference LLP | January 29, 2025 A2Z Cust2Mate Solutions Corp $30,000,000 Registered Direct Offering Public Offering January 2025 Read More
Sichenzia Ross Ference Carmel LLP represents Calidi Biotherapeutics, Inc. in $4.25 Million Public Offering By Sichenzia Ross Ference LLP | January 15, 2025 Calidi Biotherapeutics, Inc. $4,250,000 Public Offering January 2025 Read More
Sichenzia Ross Ference Carmel LLP represents KULR Technology Group, Inc. in a $50 Million Upsizing under an At The Market Offering Agreement By Sichenzia Ross Ference LLP | December 30, 2024 KULR Technology Group, Inc. $50,000,000 At-the-Market December 2024 Read More
Sichenzia Ross Ference Carmel LLP represents KULR Technology Group, Inc. in a $26 Million Upsizing of an At The Market Offering By Sichenzia Ross Ference LLP | December 22, 2024 KULR Technology Group, Inc. $26,000,000 At-the-Market December 2024 Read More
Sichenzia Ross Ference Carmel LLP Represents The Coretec Group in an aggregate $17.15 Million Private Placement Offering of Preferred Stock By Sichenzia Ross Ference LLP | December 22, 2024 The Coretec Group $17,150,000 Private Placement December 2024 Read More
Sichenzia Ross Ference Carmel LLP Represents A2Z Cust2Mate Solutions Corp. in $12.5 Million Registered Direct Offering By Sichenzia Ross Ference LLP | December 17, 2024 A2Z Cust2Mate Solutions Corp. $12,500,000 Registered Direct Offering December 2024 Read More
Sichenzia Ross Ference Carmel LLP Represents A.G.P/Alliance Global Partners in $8 Million Private Placement of TransCode Therapeutics By Sichenzia Ross Ference LLP | December 4, 2024 TransCode Therapeutics $8,000,000 Private Placement December 2024 Read More
Sichenzia Ross Ference Carmel LLP 代表 A.G.P/Alliance Global Partners 对 TransCode Therapeutics 进行 800 万美元私募 By Sichenzia Ross Ference LLP | December 4, 2024 TransCode Therapeutics $8,000,000 Private Placement December 2024 Read More
Sichenzia Ross Ference Carmel LLP represents Calidi Biotherapeutics, Inc. in $7.5 Million Public Offering By Sichenzia Ross Ference LLP | November 14, 2024 Calidi Biotherapeutics, Inc. $7,500,000 Public Offering October 2024 Read More
Sichenzia Ross Ference Carmel LLP represents BullFrog AI Holdings, Inc. in $3.13 Million Registered Direct Offering and Concurrent Private Placement By Sichenzia Ross Ference LLP | October 24, 2024 Bullfrog AI $3,130,000 Registered Direct October 2024 Read More